Azenta 

€18.2
28
+€0.2+1.11% Today

Statistics

Day High
17.6
Day Low
17.6
52W High
34.8
52W Low
17.1
Volume
-
Avg. Volume
-
Mkt Cap
1.35B
P/E Ratio
52.21
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 21
€0.09
Sep 21
€0.08
Jun 21
€0.08
Mar 21
€0.08
Dec 20
€0.08
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

11MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.05
0.1
0.16
0.21
Expected EPS
0.117571
Actual EPS
N/A

Financials

-9.55%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.04BRevenue
-99.28MNet Income

Analyst Ratings

$31.87Average Price Target
The highest estimate is 34.15.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
75%
Hold
25%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BA3.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers similar life sciences solutions and services, including automation, cryogenic solutions, and genomic analysis, directly competing with Azenta's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories provides a range of products and services for life science research and clinical diagnostics, overlapping with Azenta's market in genomic and cellular analysis.
Illumina
ILMN
Mkt Cap18.99B
Illumina specializes in DNA sequencing and array-based technologies, competing in the genomics space where Azenta also operates.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies offers comprehensive solutions in life sciences, diagnostics, and applied chemical markets, including lab automation and genomics, competing with Azenta.
Waters
WAT
Mkt Cap20.81B
Waters Corporation provides analytical standards and reagents, chromatography, and mass spectrometry solutions that serve similar research and pharmaceutical markets as Azenta.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation offers scientific instruments and analytical and diagnostic solutions that compete in the life sciences sector, similar to Azenta's market.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation's life sciences segment offers a broad range of research and clinical tools, directly competing with Azenta in several areas including diagnostics and genomic solutions.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the genomics and diagnostics space with Azenta.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories, through its Class B shares, represents an alternative investment in the same company as ticker BIO, offering similar competitive pressures in the life sciences and clinical diagnostics markets.

About

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Show more...
CEO
Mr. John P. Marotta
Employees
3000
Country
US
ISIN
US1143401024
WKN
000257275

Listings

0 Comments

Share your thoughts

FAQ

What is Azenta stock price today?
The current price of BA3.F is €18.2 EUR — it has increased by +1.11% in the past 24 hours. Watch Azenta stock price performance more closely on the chart.
What is Azenta stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Azenta stocks are traded under the ticker BA3.F.
Is Azenta stock price growing?
BA3.F stock has fallen by -0.55% compared to the previous week, the month change is a -19.47% fall, over the last year Azenta has showed a -42.41% decrease.
What is Azenta market cap?
Today Azenta has the market capitalization of 1.35B
When is the next Azenta earnings date?
Azenta is going to release the next earnings report on May 11, 2026.
What were Azenta earnings last quarter?
BA3.F earnings for the last quarter are 0.08 EUR per share, whereas the estimation was 0.12 EUR resulting in a -34.84% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Azenta revenue for the last year?
Azenta revenue for the last year amounts to 1.04B EUR.
What is Azenta net income for the last year?
BA3.F net income for the last year is -99.28M EUR.
Does Azenta pay dividends?
Yes, BA3.F dividends are paid quarterly. The last dividend per share was 0.09 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Azenta have?
As of April 01, 2026, the company has 3,000 employees.
In which sector is Azenta located?
Azenta operates in the Health Care sector.
When did Azenta complete a stock split?
Azenta has not had any recent stock splits.
Where is Azenta headquartered?
Azenta is headquartered in Burlington, US.